Literature DB >> 1174487

Quantitative lacrimal scintillography. II. Lacrimal pathology.

J J Hurwitz, M N Maisey, R A Welham.   

Abstract

Quantitative lacrimal scintillography is a useful clinical procedure in assessing lacrimal drainage function in patients with epiphora. Examples are presented of patients with canalicular disease, lid abnormalities, 'functional blocks', and dysthroid disease, in which this technique was valuable. Information regarding the dynamics of a functioning and non-functioning dacryocystorhinostomy is elucidated with quantitative scintillography.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174487      PMCID: PMC1042628          DOI: 10.1136/bjo.59.6.313

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Quantitative lacrimal scintillography. I. Method and physiological application.

Authors:  J J Hurwitz; M N Maisey; R A Welham
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

2.  Problems of lacrimal obstruction; rhinological approach.

Authors:  T K LYLE
Journal:  Trans Ophthalmol Soc U K       Date:  1956

3.  Canalicular obstruction and the Lester-Jones tube what to do when all else fails.

Authors:  R A Welham
Journal:  Trans Ophthalmol Soc U K       Date:  1973

4.  A new method of evaluating lacrimal drainage.

Authors:  R M Rossomondo; W H Carlton; J H Trueblood; R P Thomas
Journal:  Arch Ophthalmol       Date:  1972-11

5.  Clinical evaluation of microscintigraphy of the lacrimal drainage apparatus.

Authors:  W H Carlton; J H Trueblood; R M Rossomondo
Journal:  J Nucl Med       Date:  1973-02       Impact factor: 10.057

6.  The mechanism of the lacrimal flow.

Authors:  J A Brienen; C A Snell
Journal:  Ophthalmologica       Date:  1969       Impact factor: 3.250

7.  Long-term prognosis in malignant exophthalmos.

Authors:  R Riise
Journal:  Acta Ophthalmol (Copenh)       Date:  1970

8.  The gusto-lacrimal reflex (syndrome of crocodile tears). Report of cases with tear analysis.

Authors:  H N Jacklin
Journal:  Am J Ophthalmol       Date:  1966-06       Impact factor: 5.258

9.  Surgical management of orbital tarsal disparity.

Authors:  M W Bick
Journal:  Arch Ophthalmol       Date:  1966-03
  9 in total
  8 in total

1.  Evaluation of Patients for Endoscopic DCR: Sac Syringing and Radionuclide Scintigraphy.

Authors:  Col Uma Patnaik; Maj Atul Gupta; Brig Ajith Nilakantan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-16

2.  Clinical value of dacryoscintigraphy using a simplified analysis.

Authors:  P L Jager; K Mansour; H Vrakkink-de Zoete; L Poot; J M M Hooijmans; K J Bruin; L J Blanksma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-18       Impact factor: 3.117

3.  Radiography in functional lacrimal testing.

Authors:  J J Hurwitz; R A Welham
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

4.  Testing of lacrimal drainage with the aid of a gamma-ray emitting radiopharmaceutical (99m TcO4).

Authors:  L J Blanksma; N M Schweitzer; H Beekhuis; D A Piers
Journal:  Doc Ophthalmol       Date:  1977-02-28       Impact factor: 2.379

5.  Clinical and scintigraphic comparison of silicone and polyvinylpyrrolidone coated silicone perforated plugs.

Authors:  T Malet; B Challier; N David; A Bertrand; J L George
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

6.  Role of lacrimal scintigraphy and subtraction macrodacryocystography in the management of epiphora.

Authors:  L A Amanat; E P Wraight; P G Watson; T D Hawkins
Journal:  Br J Ophthalmol       Date:  1979-07       Impact factor: 4.638

7.  Lacrimal scintigraphy. II. Its role in the diagnosis of epiphora.

Authors:  L A Amanat; T E Hilditch; C S Kwok
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

8.  Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.

Authors:  A Urtti; H Rouhiainen; T Kaila; V Saano
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.